NeuroOne Corp (NMTC) - Net Sales Margin

NeuroOne (NMTC) - corporate logo

Risks are associated with ESG compliance costs and waste disposal during electrode production for NeuroOne Medical Technologies (NMTC). The integral net margin indicator visualizes these expenses, where the value -78.60 determines the status of the profitability parameter. Stability is ensured by the uniqueness of the brain mapping equipment, which creates pricing power. Expansion into the neurosurgery niche through innovation helps NeuroOne Medical Technologies (NMTC) compete effectively against market behemoths.

NeuroOne Medical Technologies Corp. (NMTC) - Return on Sales by Net Profit from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for NeuroOne Medical Technologies (NMTC)

- share price and expert price forecast:
Manufactured product of NeuroOne Medical Technologies Corp.

NeuroOne Medical Technologies (NMTC) is expanding its presence in the neurosurgical electrode market through a growing US customer base. This metric determines the net profit share of every dollar of revenue, reflecting the overall profitability of the business. By analyzing the sales efficiency ratio based on net profit, an investor gains a real-time assessment of cost management without quarterly lags. This price action reflects the immediate market reaction of margins to economic phases, protecting capital from buying at market peaks.

Analysis of competing companies

BSX: Net Sales Margin|Return on Sales by Net Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Net Sales Margin|OmniPod (PODD) - Company Sales Margin|Net Sales Margin ZBH|Net Sales Margin coopercos.com (COO)|Net Sales Margin ALGN (aligntech.com)|Net Sales Margin Globus Medical Inc GMED|TMDX - Net Margin|ATEC: Net Margin|AORT (Artivion, Inc.) - Return on Sales by Net Profit|Enovis Corporation - Net Profit Rate|IART (Integra LifeSciences Inc.) - Net Sales Margin|Net Margin Establishment Labs Corp ESTA|Net Margin Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Net Profitability Margin|Embecta Health - Return on Sales by Net Profit|Net Sales Margin Tandem Diabetes Care TNDM|AxoGen Inc - Net Sales Margin|Company Sales Margin SI-BONE Inc SIBN|Orthofix (OFIX) - Net Margin|Return on Sales by Net Profit Bioventus Corp|Net Margin orthopediatrics.com|Return on Sales by Net Profit Treace Medical Concepts (TMCI)|Net Sales Margin SRTA|CARL - Net Margin|Net Margin RxSight, Inc. RXST|CLPT: Net Return on Sales|STXS: Return on Sales by Net Profit|neurostar.com - Company Net Profitability|Sight Sciences Inc. (SGHT) - Net Margin|Net Margin orchestrabiomed.com (OBIO)|Net Margin Anika Therapeutics, Inc.|Net Return on Sales NSPR (InspireMD Inc.)|Net Margin Jin Medical International Ltd (ZJYL)|Net Margin VANI (Vivani Medical)|Net Margin xtantmedical.com XTNT|Net Sales Margin Modular Medical MODD|MYO: Return on Sales by Net Profit|Net Margin Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Return on Sales by Net Profit|Net Return on Sales NVNO|Return on Sales by Net Profit SINT|Return on Sales by Net Profit Tenon Medical (TNON)|Net Margin ReWalk Robotics Ltd (LFWD)|Company Sales Margin Autonomix|Net Sales Margin IVF (invobioscience.com)|bonebiologics.com - Net Margin|AXNX - Net Margin|BIOL (BIOLASE) - Net Return on Sales|Dynatronics Corporation (DYNT) - Net Margin|Net Return on Sales FNA|INVO (INVO Bioscience Inc.) - Net Sales Margin